Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.

Despite the advances in pre-, peri- and post-operative medical care of colorectal carcinoma patients, the prognosis has improved only marginally over recent decades. Thus, additional prognostic indicators would be of great clinical value to select patients for adjuvant therapy. In previous studies w...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganesh, S., Sier, C. F., Heerding, M. M., van Krieken, J. H., Griffioen, G., Welvaart, K., van de Velde, C. J., Verheijen, J. H., Lamers, C. B., Verspaget, H. W.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223607/
https://www.ncbi.nlm.nih.gov/pubmed/9192984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223607/
https://www.ncbi.nlm.nih.gov/pubmed/9192984

Ejemplares similares